London Health Sciences Centre
339 Windermere Road
London Ontario Canada
Phone: (519) 663 - 3624
Delaying Alzheimer's disease
Professor of Neurology, University of Western Ontario; Distinguished University Professor
Dr. Hachinski received his MD from the University of Toronto. After completing his residency training at the same university, Dr. Hachinski undertook a Cerebrovascular Laboratory fellowship at the National Hospital for Nervous Diseases at Queen Square in London, England and a research fellowship at Bispebjerg Hospital in Copenhagen, Denmark.
Dr. Hachinski is Professor of Neurology and Distinguished University Professor at the University of Western Ontario and President of the International Society for Vascular Behavioural and Cognitive Disorders and First Vice-President of the World Federation of Neurology. An international expert on stroke prevention, he introduced the concepts and terms for leukoaraiosis and multi-infarct dementia as well as devised the Ischemic Score, which remains a standard for distinguishing Alzheimer from multi-infarct dementia.
He is Editor-in-Chief of Stroke Journal, the leading publication in the field. He has contributed to over 600 book chapters, scientific papers, editorials and other scholarly publications. He is the author of 17 books including Stroke: A comprehensive Guide to Brain Attack, co-authored with his daughter Larissa Hachinski, which was written to increase public awareness of “brain attacks,” a term coined by Dr. Hachinski to help drive home the urgency of strokes.
He has received 3 honorary degrees, the Mihara International Award and the Order of Canada.
Dr. Hachinski’s research involves clinical and experimental studies in the prevention and delay of stroke and Alzheimer’s disease in collaboration with David F. Cechetto of Western’s department of anatomy. He has observed with the use animal models that levels of protein amyloid increases and causes inflammation and damage when a stroke is produced. To combat this, he has researched drugs that can be given to reduce inflammation and amyloid deposits to prevent the development of Alzheimer's after a stroke.
Hachinski’s research also includes stroke risk factor controls. Only one in five of those with high blood pressure and high cholesterol have it normalized and in order to control these factors, Drs. Richard Chan and Vladimir Hachinski and their research team are using trained volunteers to work with high-risk patients for better control of their vascular risk factors.